In clinical practice LIRA was associated with significantly greater reductions in A1C and improved glycemic goal attainment compared with either EXEN or SITA among adult patients with T2D (Diabetes, Obesity and Metabolism)
Diabetes News Service
In clinical practice LIRA was associated with significantly greater reductions in A1C and improved glycemic goal attainment compared with either EXEN or SITA among adult patients with T2D (Diabetes, Obesity and Metabolism)
For iPhone and iPad | For Android devices
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
Website by Wired up Wales